Pain Management Nursing Guide

Assessment tools, WHO analgesic ladder, multimodal analgesia, opioid safety, and GCC-specific considerations

WHO Ladder Multimodal Analgesia Opioid Safety Neuropathic Pain

Definition of Pain (IASP 2020)

"An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage."

Key update (2020): Pain is ALWAYS subjective. A patient's report of pain is the gold standard — it does not require objective evidence of tissue damage. Pain exists even if no cause is found.

Types of Pain

TypeMechanismCharacterExamples
Nociceptive — somaticTissue damage activating nociceptorsAching, throbbing, well-localisedFracture, surgical wound, arthritis
Nociceptive — visceralHollow organ distension/ischaemiaCramping, colicky, poorly localised, referredRenal colic, bowel obstruction, MI
NeuropathicNerve damage or dysfunctionBurning, shooting, electric shock, allodynia, hyperalgesiaPHN, diabetic neuropathy, sciatica
NociplasticAltered nociception without clear tissue damageWidespread, variable, associated with sensitisationFibromyalgia, IBS, chronic widespread pain

Pain Assessment Tools

ToolUseHow
NRS (Numerical Rating Scale)Adults able to self-report0 = no pain, 10 = worst imaginable
VAS (Visual Analogue Scale)Adults; research settings10cm line; patient marks position
Wong-Baker FACESChildren ≥3 years; some adults6 faces from happy (0) to crying (10)
Abbey Pain ScaleDementia; non-verbal adultsObservational: vocalisation, facial, body language, behaviour change, physiological, physical
CPOT (Critical-Care Pain Observation Tool)Intubated/ICU patients4 domains: facial expression, body movement, muscle tension, compliance with ventilator
FLACCNeonates/infants/preverbal childrenFace, Legs, Activity, Cry, Consolability — 0–10

Comprehensive Pain Assessment: SOCRATES

  • Site — where is the pain?
  • Onset — when did it start? sudden or gradual?
  • Character — burning, stabbing, aching, throbbing?
  • Radiation — does it spread anywhere?
  • Associations — nausea, vomiting, numbness?
  • Time — constant or intermittent? worse at certain times?
  • Exacerbating/relieving factors — movement, heat, analgesia?
  • Severity — NRS 0–10

WHO Analgesic Ladder

StepPain LevelDrugs
Step 1Mild (NRS 1–3)Paracetamol ± NSAIDs (ibuprofen, diclofenac, naproxen)
Step 2Moderate (NRS 4–6)Weak opioids: codeine, tramadol, dihydrocodeine + Step 1 drugs
Step 3Severe (NRS 7–10)Strong opioids: morphine, oxycodone, fentanyl, hydromorphone + Step 1 drugs
Multimodal analgesia = combining drugs with different mechanisms to achieve better pain control with lower doses of each drug, reducing side effects. Opioid-sparing is the goal.

Opioid Side Effects — CONS Mnemonic

  • C — Constipation (tolerance does NOT develop — prescribe laxatives from day 1)
  • O — Obtundation (sedation, altered consciousness)
  • N — Nausea and vomiting (particularly on initiation)
  • S — Sweating (and pruritus, dry mouth)
  • + Respiratory depression — most dangerous; monitor respiratory rate and sedation level
  • + Urinary retention — particularly in elderly men
  • + Dependence and tolerance with long-term use
Monitor SEDATION level before respiratory rate — sedation precedes respiratory depression. Sedation score ≥2 = reduce opioid dose immediately.

Opioid Reversal — Naloxone

  • Naloxone 0.4mg IV/IM/SC — competitive opioid antagonist
  • Onset: IV 1–2 min; IM 2–5 min
  • Duration: 30–90 min (shorter than most opioids — re-narcotisation can occur)
  • Titrate in small doses (0.04–0.1mg) in opioid-dependent patients to avoid precipitating acute withdrawal
  • Repeat doses may be required; consider naloxone infusion for long-acting opioids

Patient-Controlled Analgesia (PCA)

  • Bolus dose prescribed by anaesthetist/pain team (typically morphine 1mg)
  • Lockout interval: 5–8 minutes (prevents double-dosing)
  • Background infusion: generally avoided (increases respiratory depression risk)
  • Monitor SEDATION level, not just pain score
  • Only the PATIENT should press the PCA button — not family, not nurses
  • Hourly observations: RR, SpO₂, sedation score, pain score

Neuropathic Pain Management

Drug ClassExamplesNotes
TCA (first-line)Amitriptyline 10–75mg nocteAnticholinergic side effects; sedation; low dose for pain vs higher for depression
SNRI (first-line)Duloxetine 60mg dailyAlso used for fibromyalgia and diabetic neuropathy specifically
Anticonvulsant (first-line)Pregabalin 75–300mg BD; GabapentinPregabalin has faster titration; both cause dizziness, weight gain; controlled drug in UK
TopicalLidocaine patches, capsaicin 8% patchLocalised neuropathic pain; minimal systemic effects
OpioidsTramadol, oxycodoneSecond or third line; limited efficacy in pure neuropathic pain

Opioid-Induced Respiratory Depression

Clinical signs: RR <8/min, SpO₂ <92%, miosis (pin-point pupils), reduced GCS, cyanosis. ACT IMMEDIATELY — this is life-threatening.
  • Stop opioid infusion / PCA immediately
  • Call for help; apply high-flow oxygen
  • Naloxone 0.4mg IV/IM — repeat every 2–3 min up to 3 doses
  • If no IV access: IM, SC, or intranasal naloxone
  • Monitor for re-narcotisation after naloxone wears off (30–90 min)
  • Document and complete incident report

Chronic Pain and Psychological Dimensions

  • Chronic pain (>3 months) involves central sensitisation and psychosocial factors
  • Biopsychosocial model: biological + psychological (fear-avoidance, catastrophising) + social (work, family)
  • CBT (cognitive behavioural therapy) is evidence-based for chronic pain
  • Pain management programmes (PMP) — multidisciplinary
  • Opioids have limited efficacy in chronic non-cancer pain; escalation often unhelpful
  • Physical activity and rehabilitation are cornerstones

Opiophobia in GCC Clinical Practice

Opiophobia — excessive fear of prescribing opioids — is prevalent among GCC clinicians and patients, leading to undertreated pain, particularly in cancer, post-operative, and palliative settings.
  • Cultural and religious attitudes may associate opioids with addiction or loss of consciousness
  • Nurses should advocate for adequate analgesia as a patient right
  • WHO guidance emphasises adequate pain relief as an ethical and human rights obligation
  • Education programmes on opioid safety vs opioid phobia are needed

Controlled Drug Regulations in GCC

  • DHA (Dubai), SFDA (Saudi Arabia), MOH various GCC countries — strict controlled substance regulations
  • Opioids require specific prescriber licensing (Triplicate/special prescription forms)
  • Storage: double-locked controlled drug cupboard; two-nurse checking system for administration
  • Wastage must be witnessed and documented by two registered nurses
  • Patient-owned opioids: hospital policy governs whether patients may self-administer
  • Import of personal opioid medications requires prior DHA/MOH approval for travellers

Ramadan and Pain Management

Islamic scholars and GCC health authorities confirm: IV and IM medications given for therapeutic purposes do NOT break the Ramadan fast. This includes opioids, analgesics, and IV fluids.
  • Oral medications are generally considered to break the fast — some scholars allow oral medications with medical necessity
  • Suppository analgesia — some scholars consider this acceptable; others disagree — patient should consult their religious authority
  • Nurse's role: provide accurate information; facilitate patient's choice; never withhold necessary analgesia

High-Yield Exam Points

  • IASP 2020 definition: pain is always SUBJECTIVE — self-report is gold standard
  • CPOT for intubated ICU patients; FLACC for neonates; Abbey for dementia; FACES for children
  • WHO Ladder: Step 1 (mild) = non-opioids; Step 2 (moderate) = weak opioids; Step 3 (severe) = strong opioids
  • Opioid side effects CONS: Constipation, Obtundation, Nausea, Sweating
  • Naloxone 0.4mg IV = opioid reversal
  • PCA: bolus + lockout 5–8 min; monitor SEDATION not just pain; only patient presses button
  • Neuropathic first-line: amitriptyline, duloxetine, pregabalin
  • Multimodal = opioid-sparing = better pain control with fewer side effects
  • Constipation is the ONE opioid side effect tolerance does NOT develop to

Common Exam Traps

  • Monitor SEDATION before respiratory rate — sedation is the earlier warning sign
  • Naloxone duration (30–90 min) is SHORTER than most opioids — re-narcotisation is possible
  • Background PCA infusion INCREASES respiratory depression risk — generally avoided
  • NSAIDs are CONTRAINDICATED in renal failure, active GI ulceration, severe asthma
GCC Clinical Practice Insights
DHA Controlled Drug Handling Requirements +
DHA regulations require controlled drugs (including opioids) to be stored in a double-locked cupboard, with a separate register. Each administration must be witnessed by two registered nurses. Discrepancies must be reported immediately to the nurse in charge. All wastage must be witnessed, documented with both nurses' signatures, and disposed of per DHA protocol.
SFDA Opioid Prescribing Requirements (Saudi Arabia) +
The Saudi Food and Drug Authority (SFDA) controls all narcotics and psychotropic substances. Opioid prescribing requires a licensed prescriber with narcotics prescribing authority. Special prescription forms are required. Hospitals must maintain strict narcotics registers with monthly reconciliation submitted to the SFDA.
Cancer Pain and Palliative Care in GCC +
Palliative care services are growing in the GCC, but opioid availability for cancer pain remains a challenge in some settings. The WHO identifies opioid access as a global health priority. Nurses working in oncology and palliative care settings in the GCC should advocate for adequate analgesia and be familiar with morphine equivalency calculations for opioid rotation.
Post-Operative Pain Management in GCC Hospitals +
Acute Pain Services (APS) are established in most large GCC hospitals. ERAS protocols incorporating multimodal analgesia (paracetamol + NSAIDs + regional blocks + minimal opioids) are increasingly standard. Nurse-led PCA management with standardised observation protocols (RR, SpO₂, sedation score) is well-established in JCI-accredited facilities.
Practice MCQs

Q1. A patient in the ICU is intubated and sedated following abdominal surgery. Which pain assessment tool is most appropriate?

Correct answer: B — CPOT is validated for intubated ICU patients who cannot self-report. It assesses 4 behavioural domains: facial expression, body movements, muscle tension, and compliance with the ventilator. NRS requires verbal response; FACES requires visual ability; Abbey is designed for dementia patients.

Q2. A patient on a morphine PCA develops increasing sedation with RR of 10/min and SpO₂ 90%. What is the PRIORITY action?

Correct answer: C — This patient has opioid-induced respiratory depression (RR <8 is critical but 10 + SpO₂ 90% with sedation = emergency). Stop opioid immediately, apply O₂, administer naloxone 0.4mg IV, call for help. Sedation is an early warning sign — once SpO₂ drops, act immediately.

Q3. Which drug class is recommended as first-line treatment for diabetic peripheral neuropathic pain?

Correct answer: C — Pregabalin (α2δ calcium channel blocker) and duloxetine (SNRI) are both first-line evidence-based treatments for diabetic neuropathic pain per NICE and international guidelines. Amitriptyline is also first-line. NSAIDs and opioids have minimal efficacy in pure neuropathic pain.

Q4. Regarding PCA morphine, which statement is correct?

Correct answer: B — Only the patient should activate the PCA. This is the fundamental safety mechanism — the patient cannot press the button if they are too sedated, preventing overdose. Background infusions increase risk. Lockout is 5–8 min. Sedation score must be monitored, not just RR.